News – Ypsomed Delivery Systems

Burgdorf / Mainz / Basel – Ypsomed advances its patch injector into a comprehensive solution by entering into a collaboration with SCHOTT, one of the leading suppliers of pharmaceutical primary packaging, and Lonza, a leading global partner of the pharmaceutical and biotechnology industry for the development, manufacturing and testing of pharmaceuticals. In a joint effort, the three companies are developing a comprehensive solution for wearable patch injectors for the subcutaneous self-injection of large volumes of liquid formulations. This solution should enable pharmaceutical companies to quickly bring biopharmaceuticals in a patch injector into the clinical trial stage and to the market. For patients, the solution reduces the number of hospital visits required for treatment.

World's first zero carbon emission autoinjector from Ypsomed

News – Ypsomed Delivery Systems

Burgdorf – Ypsomed has developed the world’s first zero carbon emission prefilled autoinjector. The YpsoMate Zero is based on the proven YpsoMate autoinjector platform that offers convenient handling and patient safety. The new YpsoMate Zero uses alternative biopolymers and a novel packaging design that follows the principles of circular product design.

Ypsomed's autoinjector YpsoMate

Promising start-up opts for Ypsomed's user-friendly autoinjector to treat PMDD

News – Ypsomed Delivery Systems

Asarina Pharma has decided to go with our user-friendly two-step autoinjector YpsoMate for its commercial launch of its drug Sepranolone. Sepranolone is the world’s first treatment for pre-menstrual dysphoric disorder (PMDD).

Market entry of YpsoMate autoinjector for Teribone™ in Japan
Teribone™ autoinjector

News – Ypsomed Delivery Systems

Burgdorf – Terumo Corporation (Terumo), a leading global manufacturer and distributor of medical devices, will fill its PLAJEX™ syringe with the drug Teribone™ and assemble it with the YpsoMate prefilled autoinjector from Ypsomed. Teribone™ is a Teriparatide for the treatment of osteoporosis. The drug was developed by Asahi Kasei Pharma (AKP) and will be launched in Japan.

YpsoDose patch injector in use

Satisfied user study participants

News – Ypsomed Delivery Systems

YpsoDose is a patch injector for large volumes. When developing YpsoDose, we focus on user-friendliness as we do with all our injection systems. The latest user studies have confirmed how easy YpsoDose is to use. 

Ypsomed's autoinjector YspoMate

YpsoMate's platform approach is paying off

News – Ypsomed Delivery Systems

Several customers have recently launched their autoinjectors based on our YpsoMate platform product technology on the market. Customers value the fast product customisation as well as the individual design possibilities. End users appreciate its user-friendliness.

News – Ypsomed Delivery Systems

Ypsomed Delivery Systems is presenting its range of self-injection device platforms at CPhI in Frankfurt, 5-7 November 2019.

News – Ypsomed Delivery Systems

Ypsomed is excited to participate at the PDA The Universe of Prefilled Syringes and Injection Devices in Gothenburg, Sweden, 22 - 23 October 2019.

News – Ypsomed Delivery Systems

Ian Thompson, Business Development, and Christoph Berger, Innovation Officer, will be attending PODD: Partnerships in Drug Delivery in Boston on 7-8 October. We look forward to discussing the latest drug delivery trends with you, in addition to Ypsomed’s patch injector and connected platform products and services.

News – Ypsomed Delivery Systems

Ypsomed is showcasing its complete range of self-injection devices at the upcoming CPhI China in Shanghai June 18-20, 2019.